Rethinking Male Hygiene to Protect Maternal Health

Bacterial vaginosis (BV) affects between 23% and 29% of women of reproductive age globally, and is among the most common conditions associated with preterm birth, low birth weight, and ascending intrauterine infection. Despite decades of treatment, recurrence rates remain high — in clinical trials, BV recurrence within 12 weeks of antibiotic treatment has reached 63%.

A growing body of evidence points to why: current treatments focus exclusively on the female partner, ignoring the male genital tract as a potential reservoir for anaerobic bacteria. Prospective cohort studies have demonstrated that the microbiome composition of a man's penis can predict incident BV in his female partner with over 80% accuracy. Without addressing this reservoir, reinfection is a predictable outcome.

Preterm birth remains the leading driver of neonatal mortality globally, responsible for more than one-third of neonatal deaths. The causal link between vaginal dysbiosis and spontaneous preterm birth is now well-established. Addressing the root of that dysbiosis — including partner transmission — may be one of the most underexplored opportunities in maternal health research.

Circunaro is investigating a medical-grade silicone ring designed to reduce the anaerobic microenvironment under the foreskin — the conditions that support pathogenic bacterial communities associated with BV transmission. The hypothesis draws directly from the mechanism behind surgical male circumcision, which has been shown in randomized trials to reduce BV risk in female partners by 40–61%. The Circunaro device proposes to achieve a comparable ecological shift without surgery.